Clera - Your AI talent agent
LoginStart
Start
Kyverna Therapeutics logo
Kyverna Therapeutics

Senior Director, Market Access, Health Economics, Outcomes Research & Value

full-time•$280k - $305k

Summary

Salary

$280k - $305k

Type

full-time

Experience

10+ years

Company links

WebsiteLinkedInLinkedIn

About this role

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.


Position Overview

Kyverna is seeking a Senior Director, Market Access, Health Economics, Outcomes Research (HEOR) & Value to lead the global HEOR and value strategy across the portfolio, spanning early development through commercialization. This role is accountable for defining and delivering evidence strategies that clearly articulate the clinical, economic, and humanistic value of Kyverna’s therapies to payers, HTA bodies, regulators, providers, and internal stakeholders. This role will serve as a senior cross-functional leader and strategic partner to Medical Affairs, Market Access, Commercial, Clinical Development, Regulatory, and Patient Advocacy teams.


This is a highly visible, business-critical role responsible for building scalable HEOR capabilities, shaping access and reimbursement strategies, and ensuring Kyverna’s value story is grounded in robust evidence and aligned with evolving global payer and HTA expectations.

\n


Responsibilities
  • Lead the global HEOR and value strategy across pipeline and commercial assets, ensuring alignment with overall corporate, clinical, and access objectives.
  • Develop and execute integrated evidence generation plans, including economic models, real-world evidence, patient-reported outcomes, and burden-of-disease studies to support pricing, reimbursement, and access decisions.
  • Oversee the design, development, and maintenance of global value dossiers, HTA submissions, payer value narratives, and supporting materials across key markets.
  • Partner closely with Clinical Development to embed HEOR endpoints and evidence requirements into clinical trial design and lifecycle planning.
  • Collaborate with Market Access and Commercial leadership to support pricing strategy, payer engagement, launch readiness, and post-launch optimization.
  • Serve as a senior internal advisor and escalation point on payer, HTA, and value-related questions, translating complex evidence into clear strategic recommendations.
  • Build, lead, and mentor a high-performing HEOR and value team, including internal staff and external vendors, consultants, and academic partners.
  • Ensure all HEOR activities are conducted in compliance with applicable regulations, industry standards, and internal governance frameworks.
  • Monitor evolving global payer, HTA, and policy landscapes to proactively adapt evidence strategies and inform long-term planning.


Qualifications
  •  Bachelor’s degree required. Advanced degree (MBA, PhD, PharmD, or equivalent) preferred.
  • ·Experience in specialty or rare disease sales leadership within the biotechnology or pharmaceutical industry, with a proven record of building and scaling sales organizations in pre-launch and launch settings required.
  • 12+ years experience in HEOR, market access, or value strategy within biopharma or biotech, with demonstrated leadership at a senior or executive level.
  • Deep understanding of global payer and HTA requirements, including experience supporting submissions and engagements in the US and key ex-US markets.
  • Proven track record of developing and executing evidence generation strategies across clinical development and commercialization.
  • Strong cross-functional leadership skills with the ability to influence and align senior stakeholders across the organization.
  • Experience in rare disease, autoimmune disease, cell therapy, or specialty therapeutics strongly preferred.
  • Excellent strategic thinking, communication, and executive presence, with the ability to clearly articulate value to both scientific and non-scientific audiences.
  • Successful candidates will bring strong executive presence, strategic judgment, and the ability to operate effectively in a fast-moving, high-growth environment. This role requires exceptional communication skills, a collaborative mindset, and the ability to balance high-level strategy with hands-on leadership.
  • Comfort navigating ambiguity and contributing at the executive leadership level is essential.


\n

The national salary range for this position is $280,000 to $305,000 USD annually. The final compensation will be based on individual qualifications, experience, skills, internal equity, and market alignment. This position is also eligible for an annual bonus, comprehensive benefits, and participation in the Company’s stock option plan.

What you'll do

  • Lead the global HEOR and value strategy across pipeline and commercial assets, ensuring alignment with corporate objectives. Develop and execute integrated evidence generation plans to support pricing, reimbursement, and access decisions.

About Kyverna Therapeutics

Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis. Kyverna’s pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.

Ready to join Kyverna Therapeutics?

Take the next step in your career journey

Frequently Asked Questions

What does Kyverna Therapeutics pay for a Senior Director, Market Access, Health Economics, Outcomes Research & Value?

Toggle
Kyverna Therapeutics offers a competitive compensation package for the Senior Director, Market Access, Health Economics, Outcomes Research & Value role. The salary range is USD 280k - 305k per year. Apply through Clera to learn more about the full compensation details.

What does a Senior Director, Market Access, Health Economics, Outcomes Research & Value do at Kyverna Therapeutics?

Toggle
As a Senior Director, Market Access, Health Economics, Outcomes Research & Value at Kyverna Therapeutics, you will: lead the global HEOR and value strategy across pipeline and commercial assets, ensuring alignment with corporate objectives. Develop and execute integrated evidence generation plans to support pricing, reimbursement, and access decisions..

How do I apply for the Senior Director, Market Access, Health Economics, Outcomes Research & Value position at Kyverna Therapeutics?

Toggle
You can apply for the Senior Director, Market Access, Health Economics, Outcomes Research & Value position at Kyverna Therapeuticsdirectly through Clera. Click the "Apply Now" button above to start your application. Clera's AI-powered platform will help match your profile with this opportunity and guide you through the application process.
Clera - Your AI talent agent
© 2026 Clera Labs, Inc.TermsPrivacyHelp

Join Clera's Talent Pool

Get matched with similar opportunities at top startups

This role is hosted on Kyverna Therapeutics's careers site.
Join our talent pool first to get notified about similar roles that match your profile.